180 related articles for article (PubMed ID: 24024659)
1. Secondary cancers, comorbidities and mortality associated with nitrogen mustard therapy in patients with mycosis fungoides: a 30-year population-based cohort study.
Lindahl LM; Fenger-Grøn M; Iversen L
Br J Dermatol; 2014 Mar; 170(3):699-704. PubMed ID: 24024659
[TBL] [Abstract][Full Text] [Related]
2. Subsequent cancers, mortality, and causes of death in patients with mycosis fungoides and parapsoriasis: a Danish nationwide, population-based cohort study.
Lindahl LM; Fenger-Grøn M; Iversen L
J Am Acad Dermatol; 2014 Sep; 71(3):529-35. PubMed ID: 24836079
[TBL] [Abstract][Full Text] [Related]
3. Topical nitrogen mustard therapy in patients with mycosis fungoides or parapsoriasis.
Lindahl LM; Fenger-Gron M; Iversen L
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):163-8. PubMed ID: 22229501
[TBL] [Abstract][Full Text] [Related]
4. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
Chinn DM; Chow S; Kim YH; Hoppe RT
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
[TBL] [Abstract][Full Text] [Related]
5. Nitrogen mustard revisited.
Knobler R
Br J Dermatol; 2014 Mar; 170(3):495. PubMed ID: 24617430
[No Abstract] [Full Text] [Related]
6. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience.
Kim YH; Martinez G; Varghese A; Hoppe RT
Arch Dermatol; 2003 Feb; 139(2):165-73. PubMed ID: 12588222
[TBL] [Abstract][Full Text] [Related]
7. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
Talpur R; Venkatarajan S; Duvic M
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
[TBL] [Abstract][Full Text] [Related]
8. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group.
Molin L; Thomsen K; Volden G
Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470
[TBL] [Abstract][Full Text] [Related]
9. Topical nitrogen mustard in mycosis fungoides.
Zachariae H
Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954
[TBL] [Abstract][Full Text] [Related]
10. Mycosis fungoides in young patients: clinical characteristics and outcome.
Crowley JJ; Nikko A; Varghese A; Hoppe RT; Kim YH
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):696-701. PubMed ID: 9591813
[TBL] [Abstract][Full Text] [Related]
11. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard.
Lee LA; Fritz KA; Golitz L; Fritz TJ; Weston WL
J Am Acad Dermatol; 1982 Nov; 7(5):590-8. PubMed ID: 7142467
[TBL] [Abstract][Full Text] [Related]
12. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?
Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A
Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030
[TBL] [Abstract][Full Text] [Related]
13. Nitrogen mustard gel-induced inflammation triggers lymphomatoid papulosis in patients with mycosis fungoides.
Trager MH; Chen C; Husain S; Geskin LJ
J Dermatol; 2020 May; 47(5):546-550. PubMed ID: 32100361
[TBL] [Abstract][Full Text] [Related]
14. Focal contact sensitivity to nitrogen mustard in lesions of cutaneous T-cell lymphoma (mycosis fungoides).
Shelley WB
Acta Derm Venereol; 1981; 61(2):161-4. PubMed ID: 6165197
[TBL] [Abstract][Full Text] [Related]
15. The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides.
Navi D; Riaz N; Levin YS; Sullivan NC; Kim YH; Hoppe RT
Arch Dermatol; 2011 May; 147(5):561-7. PubMed ID: 21576575
[TBL] [Abstract][Full Text] [Related]
16. Topical nitrogen mustard in early mycosis fungoides. A 12-year experience.
Zachariae H; Thestrup-Pedersen K; Søgaard H
Acta Derm Venereol; 1985; 65(1):53-8. PubMed ID: 2578706
[TBL] [Abstract][Full Text] [Related]
17. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
[TBL] [Abstract][Full Text] [Related]
18. Small malignant melanoma in patients with mycosis fungoides.
Amichai B; Grunwald MH; Goldstein J; Finkelstein E; Halevy S
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):155-7. PubMed ID: 9784043
[TBL] [Abstract][Full Text] [Related]
19. Mycosis fungoides: management with topical nitrogen mustard.
Hoppe RT; Abel EA; Deneau DG; Price NM
J Clin Oncol; 1987 Nov; 5(11):1796-803. PubMed ID: 3681368
[TBL] [Abstract][Full Text] [Related]
20. Topical chemotherapy of mycosis fungoides.
Grekin DA; Zackheim HS; Epstein EH
Cutis; 1979 Nov; 24(5):543-6. PubMed ID: 520032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]